Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical Methods for the Quantification of Drugs and Their Metabolites in Human Hair: A Systematic Review From 2010 to 2025.

Drug testing and analysis·2026
Same author

Vancomycin-Tacrolimus Combination-Related Acute Kidney Injury Risk in Posthematopoietic Stem Cell Transplant Patients.

Transplantation and cellular therapy·2026
Same author

Unsolicited Email and Predatory Solicitations: A Retrospective Case Study of a Canadian Hospital Pharmacist and the Tip of a Larger Iceberg.

The Canadian journal of hospital pharmacy·2026
Same author

[Observatory of scientific publications by Quebec pharmacists: An exploratory survey].

Annales pharmaceutiques francaises·2026
Same author

Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With Cancer.

Pediatric blood & cancer·2026
Same author

Transportability to the European Population of Efficacy of Belumosudil as Compared With Physician's Choice of Best Available Therapy for the Treatment of Chronic Graft Versus Host Disease.

Transplantation and cellular therapy·2026

Related Experiment Video

Updated: May 16, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

Prioritizing pharmaceutical activities: a simulation by pharmacy residents.

Sophie Renet1, Cynthia Tanguay, Kevin Hall

  • 1Département de Pharmacie, Unité de Recherche en Pratique Pharmaceutique, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.

Journal of Pharmacy Practice
|November 28, 2012
PubMed
Summary

Pharmacy residents in a simulation prioritized a wide range of services at a low comprehensiveness level, indicating a lack of consensus on core pharmaceutical activities. This highlights challenges in resource allocation and decision-making in pharmacy practice.

Keywords:
pharmaceutical activitiespharmacy residentsprioritization

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Related Experiment Videos

Last Updated: May 16, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

  • Pharmacy Practice
  • Healthcare Management
  • Decision Science

Background:

  • Resource constraints are a reality in healthcare settings.
  • Effective prioritization of pharmaceutical activities is crucial for optimal patient care and resource allocation.
  • Understanding decision-making processes of pharmacy residents is essential for training and practice development.

Purpose of the Study:

  • To assess the consistency of prioritization decisions made by pharmacy residents under resource constraints.
  • To identify and rank factors influencing residents' prioritization choices.
  • To compare residents' prioritization outcomes with those of Canadian pharmacy leaders.

Main Methods:

  • A simulation-based prioritization exercise was developed to evaluate pharmaceutical activity prioritization.
  • The study involved hospital pharmacy residents from two universities in Quebec.
  • Data were collected in 2011 through the simulation.

Main Results:

  • Residents managed a similar number of activities (mean 27/32), favoring breadth over comprehensiveness.
  • Perceived impact on health outcomes was prioritized over conclusive evidence.
  • While the weight of factors was similar between residents and leaders, their ranking of influential factors differed.

Conclusions:

  • Pharmacy residents tend to offer a broad spectrum of services with reduced comprehensiveness.
  • Significant variation in activity coverage among resident teams suggests a lack of agreement on essential pharmaceutical activities.
  • Findings underscore the need for standardized prioritization frameworks in pharmacy practice.